THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 143 filers reported holding THERAVANCE INC in Q2 2014. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $3,153,000 | -60.3% | 439,108 | 0.0% | 0.01% | -56.7% |
Q2 2015 | $7,935,000 | +15.0% | 439,108 | 0.0% | 0.03% | +11.1% |
Q1 2015 | $6,903,000 | +11.1% | 439,108 | 0.0% | 0.03% | +12.5% |
Q4 2014 | $6,213,000 | -17.2% | 439,108 | 0.0% | 0.02% | -20.0% |
Q3 2014 | $7,504,000 | -42.6% | 439,108 | 0.0% | 0.03% | -42.3% |
Q2 2014 | $13,077,000 | – | 439,108 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baupost Group | 19,815,983 | $338,655,000 | 5.90% |
Litespeed Management, L.L.C. | 2,670,695 | $45,642,000 | 1.76% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,790,913 | $47,697,000 | 1.76% |
Proxima Capital Management, LLC | 915,000 | $15,637,000 | 1.69% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 8,196,372 | $140,076,000 | 1.44% |
PERRY CAPITAL | 1,831,099 | $31,293,000 | 1.14% |
Roundview Capital LLC | 140,145 | $2,395,000 | 1.08% |
SECTORAL ASSET MANAGEMENT INC | 971,438 | $16,602,000 | 0.70% |
Realm Partners LLC | 139,982 | $2,392,000 | 0.68% |
BB BIOTECH AG | 743,244 | $12,702,000 | 0.52% |